Impact of Remimazolam on Prognosis After Bladder Cancer Surgery

Clinical trial NCT04532606 · RECRUITING

Trial details

NCT number: NCT04532606
Sponsor: Peking University First Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Benzodiazepines Bladder Cancer Delirium Surgery Cancer Recurrence

Start date: 2021-02-05
Primary completion: 2025-10-01
Enrollment: 1128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.